Brief: Biolidics Enters Definitive Agreement With Sysmex Corp For Cancer Diagnostics Tests
Nov 26 (Reuters) - Biolidics Ltd BIOL.SI :
* ENTERS DEFINITIVE AGREEMENT WITH SYSMEX CORP TO APPLY
EXPERTISE
FOR DEVELOPMENT OF NEW LABORATORY-DEVELOPED TESTS FOR CANCER
DIAGNOSTICS
Source text for Eikon: urn:newsml:reuters.com:*:nSNZ9Yytdr
Further company coverage: 6869.T BIOL.SI
(Reuters.Briefs@thomsonreuters.com)
Recent news on Embracing Future Holdings
See all newsBrief: Embracing Future To Buy 10% Of Embracing Future Biomedical For S$6.7 Million
Brief: Biolidics Posts FY Pretax Profit SGD -3.187 Million
Brief: Biolidics Ltd To Acquire Shenzhen Xiaozhao Network Technology
Brief: Biolidics Announces Resignation Of Song Tang Yih As Executive Director And CEO
Brief: Biolidics Announces Cybersecurity Incident